Myofibrillar Myopathy: Clinico-Genetic Spectrum From a Neuromuscular Center in South India.

Q3 Medicine
Abel Thomas Oommen, Dipti Baskar, Kiran Polavarapu, Seena Vengalil, Saraswati Nashi, Veeramani Preethish-Kumar, Sai Bhargava Sanka, Madassu Keerthipriya, Priya Treesa Thomas, Gautham Arunachal, Atchayaram Nalini
{"title":"Myofibrillar Myopathy: Clinico-Genetic Spectrum From a Neuromuscular Center in South India.","authors":"Abel Thomas Oommen, Dipti Baskar, Kiran Polavarapu, Seena Vengalil, Saraswati Nashi, Veeramani Preethish-Kumar, Sai Bhargava Sanka, Madassu Keerthipriya, Priya Treesa Thomas, Gautham Arunachal, Atchayaram Nalini","doi":"10.1097/CND.0000000000000468","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>Myofibrillar myopathy (MFM) is a group of hereditary neuromuscular disorders with heterogenous manifestations in skeletal and cardiac muscles. Little is known about phenotype-genotype spectrum of MFM in Indian population. This study aims to characterize the clinico-genetic spectrum of 12 MFM ptients from India.</p><p><strong>Methods: </strong>A detailed description of the clinical, radiological and mutation spectrum of genetically confirmed MFM patients were done.</p><p><strong>Results: </strong>The M:F ratio was 3:1. Median age of onset, presentation and illness duration were 20 (range: birth - 57 years), 31.5 (range: 6-59 years) and 9 (range: 1 - 28 years) years, respectively. Consanguinity was noted in n = 3 (25%) and motor developmental delay in n = 2 (16.7%). Clinical features noted include ptosis (n = 5, 41.7%) and ophthalmoparesis (n = 3, 25%), bifacial weakness (n = 3, 25%), flaccid dysarthria (n = 3, 41.7%), neck weakness (n = 5, 41.7%), limb-girdle weakness (n = 5, 41.7%), foot drop (n = 1, 8.3%), distal upper limb weakness (n = 2, 16.7%), proximo-distal weakness (n = 5, 41.7%), exertional dyspnoea (n = 4, 33.3%) and joint contractures (n = 8, 66.7%). Cardiac involvement (n = 4, 33.3%) including restrictive, dilated, hypertrophic cardiomyopathy. Median creatine kinase level was 884U/L (range: 347 - 3070 U/L). Muscle biopsy revealed reduced/absent sarcoplasmic desmin expression. Muscle MRI in three patients with predominant fatty infiltration in gluteus maximus and minimus, sartorius, gracilus and semitendinosus in DES; anterior and posterior compartments of distal legs in CRYAB; glutei, hamstrings, adductors of hip and legs with relative sparing of quadriceps, adductor magnus, medial gastrocnemius and peroneal muscles in TTN. Next generation sequencing (NGS) showed the most common gene involved is DES (n = 7, 58.3%) followed by other genes such as HSPB8 (n = 1), FLNC (n = 1), CRYAB (n = 1), LDB3 (n = 1) and TTN (n = 1).</p><p><strong>Conclusions: </strong>This is the first study on clinic-genetic features of MFM from India. The various novel phenotypes noted in our cohort include: CRYAB with late symptom onset without cardiac or bulbar involvement, LDB3 with early onset limb girdle syndrome, ptosis and FLNC with distal myopathy and cardiomyopathy and HSPB8 with limb girdle syndrome and ptosis, further expanding the phenotypic spectrum of MFM.</p>","PeriodicalId":39645,"journal":{"name":"Journal of Clinical Neuromuscular Disease","volume":"26 4","pages":"167-175"},"PeriodicalIF":0.0000,"publicationDate":"2025-06-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Clinical Neuromuscular Disease","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1097/CND.0000000000000468","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Objectives: Myofibrillar myopathy (MFM) is a group of hereditary neuromuscular disorders with heterogenous manifestations in skeletal and cardiac muscles. Little is known about phenotype-genotype spectrum of MFM in Indian population. This study aims to characterize the clinico-genetic spectrum of 12 MFM ptients from India.

Methods: A detailed description of the clinical, radiological and mutation spectrum of genetically confirmed MFM patients were done.

Results: The M:F ratio was 3:1. Median age of onset, presentation and illness duration were 20 (range: birth - 57 years), 31.5 (range: 6-59 years) and 9 (range: 1 - 28 years) years, respectively. Consanguinity was noted in n = 3 (25%) and motor developmental delay in n = 2 (16.7%). Clinical features noted include ptosis (n = 5, 41.7%) and ophthalmoparesis (n = 3, 25%), bifacial weakness (n = 3, 25%), flaccid dysarthria (n = 3, 41.7%), neck weakness (n = 5, 41.7%), limb-girdle weakness (n = 5, 41.7%), foot drop (n = 1, 8.3%), distal upper limb weakness (n = 2, 16.7%), proximo-distal weakness (n = 5, 41.7%), exertional dyspnoea (n = 4, 33.3%) and joint contractures (n = 8, 66.7%). Cardiac involvement (n = 4, 33.3%) including restrictive, dilated, hypertrophic cardiomyopathy. Median creatine kinase level was 884U/L (range: 347 - 3070 U/L). Muscle biopsy revealed reduced/absent sarcoplasmic desmin expression. Muscle MRI in three patients with predominant fatty infiltration in gluteus maximus and minimus, sartorius, gracilus and semitendinosus in DES; anterior and posterior compartments of distal legs in CRYAB; glutei, hamstrings, adductors of hip and legs with relative sparing of quadriceps, adductor magnus, medial gastrocnemius and peroneal muscles in TTN. Next generation sequencing (NGS) showed the most common gene involved is DES (n = 7, 58.3%) followed by other genes such as HSPB8 (n = 1), FLNC (n = 1), CRYAB (n = 1), LDB3 (n = 1) and TTN (n = 1).

Conclusions: This is the first study on clinic-genetic features of MFM from India. The various novel phenotypes noted in our cohort include: CRYAB with late symptom onset without cardiac or bulbar involvement, LDB3 with early onset limb girdle syndrome, ptosis and FLNC with distal myopathy and cardiomyopathy and HSPB8 with limb girdle syndrome and ptosis, further expanding the phenotypic spectrum of MFM.

肌原纤维肌病:来自南印度神经肌肉中心的临床-遗传谱。
目的:肌原纤维性肌病(MFM)是一组遗传性神经肌肉疾病,在骨骼肌和心肌中具有异质表现。对印度人群中MFM的表型-基因型谱了解甚少。本研究旨在描述来自印度的12例MFM患者的临床遗传谱。方法:对经遗传学证实的MFM患者的临床、放射学和突变谱进行详细描述。结果:M:F比为3:1。中位发病年龄、首发年龄和病程分别为20岁(范围:出生- 57岁)、31.5岁(范围:6-59岁)和9岁(范围:1 - 28岁)。有血缘关系的n = 3(25%),运动发育迟缓的n = 2(16.7%)。临床特征包括上睑下垂(n = 5, 41.7%)和眼瘫(n = 3, 25%)、面部无力(n = 3, 25%)、松弛性构音障碍(n = 3, 41.7%)、颈部无力(n = 5, 41.7%)、肢带无力(n = 5, 41.7%)、足下垂(n = 1, 8.3%)、上肢远端无力(n = 2, 16.7%)、近端-远端无力(n = 5, 41.7%)、用力性呼吸困难(n = 4, 33.3%)和关节挛缩(n = 8, 66.7%)。心脏受累(n = 4, 33.3%)包括限制性、扩张性、肥厚性心肌病。中位肌酸激酶水平为884U/L(范围:347 - 3070 U/L)。肌肉活检显示肌浆蛋白表达减少或缺失。以臀大肌、臀小肌、缝阔肌、股薄肌、半腱肌脂肪浸润为主的DES患者3例的肌肉MRI分析CRYAB患者远端下肢前后腔室;臀肌,腘绳肌,髋关节和腿部内收肌,股四头肌,大内收肌,腓肠肌内侧和腓肌相对保留。下一代测序(NGS)显示,最常见的基因是DES (n = 7, 58.3%),其次是HSPB8 (n = 1)、FLNC (n = 1)、CRYAB (n = 1)、LDB3 (n = 1)和TTN (n = 1)。结论:这是对印度MFM临床遗传学特征的首次研究。在我们的队列中发现的各种新表型包括:症状发作晚,无心脏或球受累的CRYAB,早发性肢带综合征,上睑下垂和FLNC,远端肌病和心肌病,以及HSPB8肢带综合征和上睑下垂,进一步扩大了MFM的表型谱。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
1.60
自引率
0.00%
发文量
64
期刊介绍: Journal of Clinical Neuromuscular Disease provides original articles of interest to physicians who treat patients with neuromuscular diseases, including disorders of the motor neuron, peripheral nerves, neuromuscular junction, muscle, and autonomic nervous system. Each issue highlights the most advanced and successful approaches to diagnosis, functional assessment, surgical intervention, pharmacologic treatment, rehabilitation, and more.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信